- Home
- ATHM vs KNSA Comparison
ATHM vs KNSA Comparison
Compare ATHM & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHM
- KNSA
- Stock Information
- Founded
- ATHM 2008
- KNSA 2015
- Country
- ATHM China
- KNSA United Kingdom
- Employees
- ATHM N/A
- KNSA N/A
- Industry
- ATHM EDP Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ATHM Technology
- KNSA Health Care
- Exchange
- ATHM Nasdaq
- KNSA Nasdaq
- Market Cap
- ATHM 3.3B
- KNSA 2.6B
- IPO Year
- ATHM 2013
- KNSA 2018
- Fundamental
- Price
- ATHM $24.13
- KNSA $40.38
- Analyst Decision
- ATHM Hold
- KNSA Strong Buy
- Analyst Count
- ATHM 1
- KNSA 7
- Target Price
- ATHM $28.00
- KNSA $49.71
- AVG Volume (30 Days)
- ATHM 328.4K
- KNSA 523.8K
- Earning Date
- ATHM 11-06-2025
- KNSA 10-28-2025
- Dividend Yield
- ATHM 9.93%
- KNSA N/A
- EPS Growth
- ATHM N/A
- KNSA N/A
- EPS
- ATHM 1.73
- KNSA 0.47
- Revenue
- ATHM $951,436,680.00
- KNSA $597,973,000.00
- Revenue This Year
- ATHM N/A
- KNSA $62.63
- Revenue Next Year
- ATHM $1.33
- KNSA $29.93
- P/E Ratio
- ATHM $14.38
- KNSA $86.35
- Revenue Growth
- ATHM N/A
- KNSA 55.68
- 52 Week Low
- ATHM $23.39
- KNSA $17.82
- 52 Week High
- ATHM $32.70
- KNSA $42.05
- Technical
- Relative Strength Index (RSI)
- ATHM 30.86
- KNSA 61.41
- Support Level
- ATHM $24.40
- KNSA $37.61
- Resistance Level
- ATHM $25.22
- KNSA $41.27
- Average True Range (ATR)
- ATHM 0.63
- KNSA 1.66
- MACD
- ATHM -0.00
- KNSA 0.14
- Stochastic Oscillator
- ATHM 3.11
- KNSA 84.78
About ATHM Autohome Inc.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.